Predictions
BayWa AG VNA
Start price
Target price
Perf. (%)
€36.90
19.02.22
19.02.22
-
19.02.23
19.02.23
-2.44%
05.03.22
05.03.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Panamax AG
Start price
Target price
Perf. (%)
€1.70
19.02.22
19.02.22
-
19.02.23
19.02.23
-55.88%
20.02.23
20.02.23
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Orpea Nom.
Start price
Target price
Perf. (%)
€36.36
19.02.22
19.02.22
€32.00
19.02.23
19.02.23
-5.42%
05.03.22
05.03.22
Risky Investment
Altur Investissement S.A.
Start price
Target price
Perf. (%)
€6.60
19.02.22
19.02.22
-
19.02.23
19.02.23
18.79%
20.02.23
20.02.23
Harmony Gold Mining ADR
Start price
Target price
Perf. (%)
€3.67
19.02.22
19.02.22
€4.30
19.03.22
19.03.22
25.07%
10.03.22
10.03.22
C.H. Robinson Worldwide Inc.
Start price
Target price
Perf. (%)
€80.00
19.02.22
19.02.22
€89.00
19.03.22
19.03.22
14.38%
10.03.22
10.03.22
Upstart Holdings Inc.
Start price
Target price
Perf. (%)
€113.30
19.02.22
19.02.22
-
19.02.23
19.02.23
-58.65%
30.05.22
30.05.22
New Oriental Education & Technology Group
Start price
Target price
Perf. (%)
€1.27
19.02.22
19.02.22
-
19.02.23
19.02.23
199.21%
20.02.23
20.02.23
Deutsche Lufthansa AG
Start price
Target price
Perf. (%)
€7.54
19.02.22
19.02.22
€11.00
19.02.23
19.02.23
29.35%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
Fair valuation
Siemens Healthineers AG
Start price
Target price
Perf. (%)
€52.60
19.02.22
19.02.22
€60.00
19.02.23
19.02.23
-4.94%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
HelloFresh SE
Start price
Target price
Perf. (%)
€48.32
19.02.22
19.02.22
€27.00
19.02.23
19.02.23
-55.07%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€182.24
19.02.22
19.02.22
€200.00
19.02.23
19.02.23
-9.80%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
Rising EBIT margin expected
Valuable balance sheet
Stable Large shareholder and/or long term investor
Viridian Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.20
19.02.22
19.02.22
€32.00
19.02.23
19.02.23
0.66%
05.03.22
05.03.22
Biorestorative Therapies Inc.
Start price
Target price
Perf. (%)
€4.32
19.02.22
19.02.22
€6.00
19.02.23
19.02.23
-1.39%
05.03.22
05.03.22